Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phosphatidylethanol-Based Contingency Management to Reduce Alcohol Use and Improve Housing Outcomes

NCT04038021 is registered in ClinicalTrials.gov with Washington State University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04038021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phosphatidylethanol-Based Contingency Management to Reduce Alcohol Use and Improve Housing Outcomes
Lead sponsor
Washington State University
Phase
Not applicable
Overall status
Completed
Start date
January 13, 2020
Completion date
October 27, 2022
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder